Unilateral Laterothoracic Exanthem in an Adult Following Recombinant Zoster Vaccination

Unilateral Laterothoracic Exanthem in an Adult Following Recombinant Zoster Vaccination

Saved in:

Bibliographic Details
Main Authors:	Xinjin Liu, Deyu Song, Xian Jiang
Format:	Article
Language:	English
Published:	Mattioli1885 2025-07-01
Series:	Dermatology Practical & Conceptual
Subjects:	Unilateral Laterothoracic Exanthema ULE Zoster vaccine adult Herpes zoster vaccination Recombinant zoster vaccine side effects
Online Access:	https://dpcj.org/index.php/dpc/article/view/5370
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States
by: Ana Florea, et al.
Published: (2024-12-01)

The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide
by: Nikolaos Giannelos, et al.
Published: (2025-05-01)

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop
by: Gyneth Lourdes G. Bibera, et al.
Published: (2024-12-01)

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024-12-01)

Cost-effectiveness analysis of herpes zoster vaccination for adults aged 50 years in Zhejiang province, China
by: Fuxing Chen, et al.
Published: (2025-05-01)

Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative NetworkResearch in context
by: Ying-Li Lin, et al.
Published: (2025-07-01)

Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
by: Giacomo Casabona, et al.
Published: (2025-12-01)

Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients
by: Sydney George, et al.
Published: (2024-12-01)

Current status of immunisation for herpes zoster
by: Anthony Lawrence Cunningham, et al.
Published: (2025-12-01)

Real-world effectiveness of recombinant herpes Zoster vaccine: a retrospective, cohort study in Japan
by: Satoko Ohfuji, et al.
Published: (2025-08-01)

Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsResearch in context
by: Ana Strezova, et al.
Published: (2025-05-01)

Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus
by: Wayne Ghesquière, et al.
Published: (2025-12-01)

Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy
by: Lucy R. Williams, et al.
Published: (2025-02-01)

Vaccination coverage, willingness and determinants of herpes zoster vaccine among individuals aged 50 and above in Ningbo, China: A population-based cross-sectional study
by: Yingying Zhu, et al.
Published: (2025-12-01)

The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain
by: Andrea García, et al.
Published: (2024-12-01)

Research Progress on Varicella-Zoster Virus Vaccines
by: Hongjing Liu, et al.
Published: (2025-07-01)

Knowledge, attitudes, and practices of the general population, herpes zoster patients, and dermatologists toward herpes zoster in China: A quantitative cross-sectional survey
by: Chun Chang, et al.
Published: (2024-12-01)

Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023
by: Jinyoung Jeong, et al.
Published: (2025-04-01)

Targeting age-appropriate adults' vaccine hesitancy to the herpes zoster vaccine in Ningbo, China: A latent profile analysis
by: Jianmei Wang, et al.
Published: (2025-06-01)

ASYMMETRIC PERIFLEXURAL (UNILATERAL LATEROTHORACIC) EXANTHEM
by: D. Yu. Ovsyannikov, et al.
Published: (2015-08-01)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024-12-01)

Evaluating the impact of the vaccination prescription program on herpes zoster vaccine coverage in Ningbo, China: An interrupted time series analysis
by: Jianmei Wang, et al.
Published: (2025-12-01)

Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis
by: Xunyi Jiao, et al.
Published: (2025-03-01)

Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience
by: Benedetta Trentacapilli, et al.
Published: (2025-02-01)

An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy
by: Francesco De Caro, et al.
Published: (2025-02-01)

Herpes zoster vaccination: Primary care provider knowledge, attitudes, and practices
by: Nikita Stempniewicz, et al.
Published: (2025-12-01)

Expanded spectrum of varicella disease and the need for vaccination in India
by: Padma Srikanth, et al.
Published: (2024-12-01)

Herpes zóster en un niño inmunocompetente
by: Paola Andrea Torres, et al.
Published: (2019-08-01)

Clinical Case of Unilateral Laterothoracic Exanthem
by: Mariya S. Vedyashkina, et al.
Published: (2020-09-01)

Herpes zoster infection in patients with inflammatory bowel disease
by: Dong Hyun Kim, et al.
Published: (2025-05-01)

Cytokine Profile in Patients with Herpes Zoster
by: O.V. Volobuieva
Published: (2024-12-01)

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy
by: Angioletta Lasagna, et al.
Published: (2023-12-01)

A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age
by: Xinghuo Pang, et al.
Published: (2024-12-01)

Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis
by: Ewa Karakulska-Prystupiuk, et al.
Published: (2025-05-01)

Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong
by: Desmond Y. H. Yap, et al.
Published: (2025-12-01)

The Association Between Herpes Zoster, Antiherpetic Therapies, and Alzheimer’s Disease: A Comprehensive Systematic Review
by: Ali Alghamdi, et al.
Published: (2025-05-01)

Awareness and acceptability of herpes zoster vaccination in people living with HIV
by: Christian Motet, et al.
Published: (2025-08-01)

Antibody Titer Against Varicella Zoster Virus and Recombinant Varicella Zoster Vaccine in Hemodialysis Patients: What We Know, What We Should Know
by: Francesca K. Martino, et al.
Published: (2025-04-01)

A Study on Determining the Level of Knowledge about Influenza, Pneumococcal, Herpes Zoster, and Tetanus Vaccines among the Vaccines Recommended by the World Health Organization and the Level of Vaccination in Individuals Sixty-Five Years Old and Over
by: Alpay Medetalibeyoğlu, et al.
Published: (2020-10-01)

Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protection Motivation Theory based study
by: Ying Gao, et al.
Published: (2025-12-01)